author-photo

Jon Amund Eriksen

Norsk Hydro

32

Papers

1412

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial

2020 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (10)
1153PAn observational clinical study with RAS peptide vaccine TG01 evaluating immune response, safety and overall survival in patients with non-resectable pancreatic cancer

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (5)
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly Asp)

2007 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (80)
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

2006 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (197)
PD-067 Telomerase peptide vaccination of patients with advancednon-small cell lung cancer —A phase I–II trial

2005 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase I/II study of telomerase peptide vaccination of patients with non-small cell lung cancer

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Polypeptides which can elicit an immune response against the cancer

2001
Show All
- Source
- Cite
- Save
Citations (0)
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant

2001 Experimental Dermatology
Show All
- Source
- Cite
- Save
Citations (36)
Intradermal ras peptide vaccination with granulocyte‐macrophage colony‐stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

2001 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (234)
A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

2001 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (63)